All news

Pharming receives US approval for expanded Ruconest production

11-Mar-2020 By Ben Hargreaves

Following on from European approval, Pharming announces the US FDA has approved its new facility for the production of its Ruconest product.

Gut bacteria could improve cancer treatment efficacy

11-Mar-2020 By Nikki Hancocks

Bifidobacteria can accumulate in tumours and improve the efficacy of cancer treatment, according to a new study in mice.

Lonza brings cell therapies from three institutes into cocoons

10-Mar-2020 By Vassia Barba

Lonza partners with three research organizations to transfer their preclinical immunotherapies development projects into the Cocoon closed automated processing platform.

In-PharmaTechnologist will soon be merging with Outsourcing-Pharma

09-Mar-2020 By Ben Hargreaves

As of March 30, coverage previously found on in-PharmaTechnologist will be hosted by our sister website, Outsourcing-Pharma.

Diversity in biotech: Inclusion lower at higher levels

09-Mar-2020 By Vassia Barba

Data published by BIO show diversity in biotech companies decreases at higher levels of management, especially in bigger, more profitable companies.

First in-vivo gene therapy administered in ‘historic event’

05-Mar-2020 By Ben Hargreaves

Allergan and Editas commence a first-in-man trial for CRISPR gene therapy for patients with inherited eye condition.

Avectas collaborates with CCRM on cell engineering tech

04-Mar-2020 By Ben Hargreaves

The two partners will look to accelerate the development of Avectas’ Solupore platform for the development of immuno-oncology and gene therapies.

Cell and gene processing moves forward through ‘experiential learning’

04-Mar-2020 By Vassia Barba

Increased manufacturing demands for cell and gene therapies drive the growth of the viral vector supply market, but challenges are still to be addressed, says Symbiosis.